Table 2 The relationship between the presence of a preoperative systemic inflammatory response and clinico-pathological characteristics of gastro-oesophageal cancer
C-reactive protein ⩽10 mg l−1 (n =105) | C-reactive protein >10 mg l−1 (n =15) | (P -value) | |
|---|---|---|---|
Age (⩽65/65–74/⩾75 years) | 54/39/12 | 6/8/1 | 0.721 |
Sex (m/f) | 72/33 | 8/7 | 0.244 |
Tumour site (oesophageal/gastric) | 54/51 | 6/9 | 0.410 |
Tumour type (adenocarcinoma/squamous) | 88/17 | 12/3 | 0.712 |
pTNM stage (I/II/III/IV) | 31/29/41/4 | 1/6/8/0 | 0.223 |
Resection margin R0/R1 | 88/15 | 11/4 | 0.235 |
Lymph node status (−/+) | 39/64 | 5/10 | 0.736 |
Positive to total lymph node ratio (0/⩽0.2/>0.2) | 39/35/29 | 5/6/4 | 0.891 |
Haemoglobin (⩾12/<12 g l−1) | 86/17 | 9/6 | 0.033 |
White cell count (<8.5/8.5–11.0/>11.0 (× 109 l−1)) | 71/25/7 | 8/5/2 | 0.204 |
Lymphocyte percentage (20–40/12–19.9/0–11.9%) | 90/11/2 | 7/6/2 | <0.001 |
Platelets (<400/⩾400 (× 109 l−1)) | 96/6 | 14/1 | 0.905 |
Albumin (⩾35/<35 g l−1) | 102/2 | 15/0 | 0.590 |
Survival (months)a | 79.2 (53.8–104.6) | 19.4 (15.3–23.4) | <0.001 |
